Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Orafyl
- Development stage
- Unknown
- Lead developer
- BioCellgraft
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
Orafyl is a flowable, decellularized human placental connective tissue matrix (HPCTM) developed for regenerative dental applications, specifically alveolar ridge preservation. Regulated as a Human Cell, Tissue, and Cellular and Tissue-Based Product (HCT/P) under Section 361 of the Public Health Service Act, Orafyl serves as a biologic scaffold that provides essential structural proteins and extracellular matrix components. These elements are intended to support tissue healing and minimize the dimensional collapse (bone resorption and soft tissue shrinkage) that typically occurs following tooth extraction. In clinical evaluation by Saint-Joseph University, Orafyl is mixed with allograft bone substitutes to maintain ridge dimensions, thereby facilitating future dental implant placement.
- Brand names
- Orafyl
- Other names
- Flowable decellularized Human Placental Connective Tissue MatrixHPCTM
Beyond the preview
Go deeper on Orafyl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orafyl.